Tag: E2
Endovascular Engineering receives two US FDA 510(k) clearances for PE thrombectomy...
Endovascular Engineering (E2) has announced that the US Food and Drug Administration (FDA) has granted 510(k) clearance for both the Hēlo thrombectomy system and...
E2 raises US$80 million series C financing for Hēlo thrombectomy platform
Endovascular Engineering (E2) today announced an oversubscribed US$80 million series C financing co-led by Gilde Healthcare and Norwest, with participation from existing investors including...